drugset / Trial / NCT01256411
A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the long-term safety, tolerability and efficacy of LCZ696.
Timeline
- Start
- 2010-11
- Primary completion
- 2012-04
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LCZ696 | Unknown | 100 mg | — |
| Subject | LCZ696 | Unknown | 200 mg | — |
| Subject | LCZ696 | Unknown | 400 mg | — |
| Background | Amlodipine | Other / unclassified | 5 mg | — |
| Background | Amlodipine | Other / unclassified | 10 mg | — |
| Background | Hydrochlorothiazide | Unknown | 12.5 mg | — |
| Background | Hydrochlorothiazide | Unknown | 25 mg | — |